Merck’s outlook for 2026 comes in lower-than-expected as pipeline faces make-or-break yearBy Mario Cazombo / February 3, 2026 Merck’s stock falls as the full-year revenue and profit outlooks were below expectations.
Book Review: The Financial Restructuring Tool Set August 6, 2025 / Book Reviews, Corporate Finance, Drivers of Value, Economics, Financial Statement Analysis, General
